Sabra Health Care REIT (NASDAQ:SBRA) Announces Earnings Results

Sabra Health Care REIT (NASDAQ:SBRA) posted its quarterly earnings results on Wednesday. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting the consensus estimate of $0.36, Zacks reports. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. Sabra Health Care REIT updated its FY 2025 guidance to 1.430-1.460 EPS.

Sabra Health Care REIT Stock Up 0.5 %

Sabra Health Care REIT stock opened at $16.55 on Thursday. The firm has a market capitalization of $3.92 billion, a P/E ratio of 40.37, a P/E/G ratio of 1.98 and a beta of 1.25. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. Sabra Health Care REIT has a twelve month low of $13.31 and a twelve month high of $20.03. The stock’s fifty day simple moving average is $16.90 and its 200-day simple moving average is $17.63.

Sabra Health Care REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Friday, February 14th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 7.25%. Sabra Health Care REIT’s dividend payout ratio is presently 292.68%.

Analyst Ratings Changes

SBRA has been the topic of several research analyst reports. JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a report on Tuesday, January 7th. Citizens Jmp upgraded shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. Mizuho reiterated a “neutral” rating and issued a $20.00 target price on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Finally, Truist Financial cut Sabra Health Care REIT from a “buy” rating to a “hold” rating and decreased their price target for the stock from $18.00 to $17.00 in a research note on Friday, January 17th. Three analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Sabra Health Care REIT currently has an average rating of “Moderate Buy” and a consensus target price of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.